Nurix Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nurix Therapeutics Inc
TickerNRIX
CIK #0001549595
CUSIP67080M103
SectorLife Sciences - Pharmaceutical Preparations
Address1700 Owens Street, Suite 205, San Francisco, CA 94158
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Nurix Therapeutics Inc 2020-03-26 120.2 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Nurix Inc 2015-09-18 17.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001549595] 10-K
[0001549595] 10-Q
[0001549595] 3
[0001549595] 4
[0001549595] 8-K
[0001549595] D
[0001549595] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Nurix Therapeutics Inc [2026-05-15] 0.0
FMR LLC Nurix Therapeutics Inc [2026-05-06] 0.0
Deep Track Capital LP Nurix Therapeutics Inc [2025-02-14] 0.0
Commodore Capital LP Nurix Therapeutics Inc [2025-02-14] 0.0
FMR LLC Nurix Therapeutics Inc [2024-12-06] 0.0
Wellington Management Group LLP Nurix Therapeutics Inc [2024-11-08] 5.41
Sands Arthur T Nurix Therapeutics Inc [2024-02-14] 5.4
Vanguard Group Inc Nurix Therapeutics Inc [2024-02-13] 5.36
Morgan Stanley Nurix Therapeutics Inc [2024-02-09] 6.4
Ark Investment Management LLC Nurix Therapeutics Inc [2024-01-29] 6.59
Deep Track Capital LP Nurix Therapeutics Inc [2023-02-24] 5.75
State Street Corp Nurix Therapeutics Inc [2023-02-10] 5.32
Wasatch Advisors Inc Nurix Therapeutics Inc [2023-02-08] 5.4
Deep Track Capital LP Nurix Therapeutics Inc [2022-06-10] 5.19
Baker Bros Advisors LP Nurix Therapeutics Inc [2022-02-14] 5.5
BlackRock Inc Nurix Therapeutics Inc [2022-02-04] 5.7
Price T Rowe Associates Inc /MD/ Nurix Therapeutics Inc [2021-08-10] 10.4
Redmile Group LLC Nurix Therapeutics Inc [2021-02-16] 7.3
Column Group L P Nurix Therapeutics Inc [2021-02-16] 8.7
Third Rock Ventures III LP Nurix Therapeutics Inc [2021-02-16] 14.0
Wellington Management Group LLP Nurix Therapeutics Inc [2020-08-10] 10.78
Foresite Capital Fund IV LP Nurix Therapeutics Inc [2020-08-03] 6.3
Form 3/4/5 Filer 2011 - 2026
Nurix Therapeutics Inc
Ring Christine
Hansen Gwenn
Saltzman Edward C
Baynes Roy D
Kapur Anil
Lacey David L
Dansey Roger D
Silva Paul M
Reinsdorf Judith A
Gregory Julia P
van Houte Hans
Sands Arthur T
Kunkel Lori Anne
Wolff Stefani
Siegall Clay B
Beaurang Pierre
Chen Leon
Tong Jeffrey K
Third Rock Ventures III LP
Third Rock Ventures GP III LP
Starr Kevin P
Levin Mark J
TRV GP III LLC
Tepper Robert I
Svennilson Peter
Column Group L P
Column Group II GP LP
Ponoi II Management LLC
Column Group II LP
Ponoi Management LLC
Kutzkey Tim
Column Group GP LP
Ponoi Capital LP
Ponoi Capital II LP
Goeddel David V
Redmile Group LLC
Green Jeremy
Wellington Biomedical Innovation Master Investors Cayman I
Tjian Robert
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ring Christine
Common Stock
2026-03-02 Sell 8,148 $15.44 125,805
Sands Arthur T
Employee Stock Option (right to buy) · derivative
2026-02-10 Grant 562,500 $0.00
Hansen Gwenn
Employee Stock Option (right to buy) · derivative
2026-02-10 Grant 93,750 $0.00
Hansen Gwenn
Restricted Stock Units · derivative
2026-02-10 Grant 42,875 $0.00
van Houte Hans
Employee Stock Option (right to buy) · derivative
2026-02-10 Grant 93,750 $0.00
Ring Christine
Employee Stock Option (right to buy) · derivative
2026-02-10 Grant 93,750 $0.00
Ring Christine
Restricted Stock Units · derivative
2026-02-10 Grant 42,875 $0.00
van Houte Hans
Restricted Stock Units · derivative
2026-02-10 Grant 42,875 $0.00
Ring Christine
Common Stock
2026-02-09 Sell 14,261 $16.66 237,588
Hansen Gwenn
Employee Stock Option (right to buy) · derivative
2026-02-03 Option exercise 31,333 $0.00
Hansen Gwenn
Common Stock
2026-02-03 Option exercise 31,333 $0.84 26,320
Ring Christine
Common Stock
2026-01-30 Sell 4,333 $16.58 71,841
Hansen Gwenn
Common Stock
2026-01-30 Option exercise 3,750 $0.00
Hansen Gwenn
Restricted Stock Units · derivative
2026-01-30 Option exercise 2,000 $0.00
van Houte Hans
Common Stock
2026-01-30 Option exercise 2,000 $0.00
Hansen Gwenn
Restricted Stock Units · derivative
2026-01-30 Option exercise 3,750 $0.00
van Houte Hans
Restricted Stock Units · derivative
2026-01-30 Option exercise 2,887 $0.00
van Houte Hans
Restricted Stock Units · derivative
2026-01-30 Option exercise 2,859 $0.00
van Houte Hans
Restricted Stock Units · derivative
2026-01-30 Option exercise 2,000 $0.00
van Houte Hans
Common Stock
2026-01-30 Sell 3,588 $16.58 59,489
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 196 113,570,227
2025-12-31 183 109,485,537
2025-09-30 174 81,373,487
2025-06-30 165 82,328,684
2025-03-31 173 79,140,695
2024-12-31 177 75,865,229
2024-09-30 174 62,159,418
2024-06-30 175 59,518,625
2024-03-31 141 51,587,464
2023-12-31 131 46,529,773
2023-09-30 131 42,190,289
2023-06-30 128 41,160,201
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 192,434 192,434
Swedbank AB [2026-06-30] DFND 65,000 65,000
PSP Research LLC [2026-06-30] SOLE 0 25,000
Gamma Investing LLC [2026-06-30] DFND 650 650
Handelsbanken Fonder AB [2026-06-30] SOLE 0 633
Farther Finance Advisors LLC [2026-06-30] SOLE 0 469
IFP Advisors LLC [2026-06-30] SOLE 224 224
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 72 72
Versant Capital Management Inc [2026-06-30] SOLE 61 61
Torren Management LLC [2026-06-30] SOLE 0 59
True Wealth Design LLC [2026-06-30] SOLE 0 36
Fortitude Family Office LLC [2026-06-30] SOLE 31 31
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com